---
title: "CASEY MICHAEL D — Ownership Dossier"
canonical: https://whiteintel.dev/entity/57790281-6bf5-5ff7-81fd-41cdb48e21db
json: https://whiteintel.dev/api/public/dossier/57790281-6bf5-5ff7-81fd-41cdb48e21db
identifier: sec:0001190435
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CASEY MICHAEL D

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001190435`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/57790281-6bf5-5ff7-81fd-41cdb48e21db  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/57790281-6bf5-5ff7-81fd-41cdb48e21db  

## Ownership & control

### Holdings / subsidiaries

- **CAPSTONE HOLDING CORP.** (director) — https://whiteintel.dev/entity/3d6d5bef-2320-59cb-8b5b-f754dd342faa
- **CELGENE CORP /DE/** (director) — https://whiteintel.dev/entity/03b6fad1-921d-55db-8db6-ba841fd1a6ac
- **CHOLESTECH CORPORATION** (director) — https://whiteintel.dev/entity/b8a6c4f2-b136-5b9c-84df-8c0ae14098ec
- **ABAXIS INC** (director) — https://whiteintel.dev/entity/173ca799-041b-5861-917d-5febfd574324
- **DURECT CORP** (director) — https://whiteintel.dev/entity/38549654-1f7a-54c0-bf81-6ca520088f04
- **Sarepta Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/e5124c31-cdb6-50b8-9569-bb5ec4c8c48d
- **ALLOS THERAPEUTICS** (director) — https://whiteintel.dev/entity/4e00b74d-beb6-5d0f-ba45-4ae0f366fc77

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CASEY MICHAEL D**. Human view: https://whiteintel.dev/entity/57790281-6bf5-5ff7-81fd-41cdb48e21db · Structured JSON: https://whiteintel.dev/api/public/dossier/57790281-6bf5-5ff7-81fd-41cdb48e21db._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._